IRONWOOD PHARMACEUTICALS INC·4

Feb 26, 5:15 PM ET

Owens Edward P 4

4 · IRONWOOD PHARMACEUTICALS INC · Filed Feb 26, 2021

Insider Transaction Report

Form 4
Period: 2021-02-24
Transactions
  • Purchase

    Class A Common Stock

    2021-02-25$9.11/sh+5,000$45,550215,954 total
  • Purchase

    Class A Common Stock

    2021-02-24$9.26/sh+7,000$64,820210,954 total
Holdings
  • Class A Common Stock

    (indirect: By Foundation)
    40,000
Footnotes (3)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.19 to $9.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.05 to $9.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F3]The reporting person and certain members of his family are trustees of the foundation, the beneficial owner of the securities. The reporting person disclaims beneficial ownership of the securities.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION